What conditions does Peter MacCallum Cancer Centre, Australia run trials for?

In our tracked recruiting trials, Peter MacCallum Cancer Centre, Australia sponsors trials for Melanoma, Prostate Cancer, Lung cancer.

Clinical trials sponsored by Peter MacCallum Cancer Centre, Australia

Recruiting trials

Conditions studied

Phase 1 2Phase 2 2Not applicable 2

Condition	Trials
Melanoma	2
Prostate Cancer	2
Lung cancer	1
Melanoma (Skin Cancer)	1
Metastatic Castration-resistant Prostate Cancer	1
NSCLC	1
Oligometastatic Prostate Cancer	1

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
NCT05521412 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
NCT07138222 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 6 locations
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT05560659 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
Metabolic Phenotypes in Melanoma
NCT05570227 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study
NCT05222087 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Peter MacCallum Cancer Centre, Australia is the lead sponsor of 5 recruiting trials.

No. For the full record, search ClinicalTrials.gov.